ACR Juvenile Idiopathic Arthritis Guidelines 2026 Update - Key Recommendations

A rapid video update of the 2026 Juvenile Idiopathic Arthritis guideline, highlighting key updates across therapeutic approaches, nonpharmacologic management, imaging recommendations, and more. Juvenile Idiopathic Arthritis American College of Rheumatology Full-Text: https://assets.contentstack.io/v3/ass... InSights: https://www.guidelinecentral.com/insi... What’s Inside: 00:00 Background 00:6 Objective 00:39 Treatment of Systemic Juvenile Idiopathic Recommendations 03:44 Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Polyarthritis, Oligoarthritis, Enthesitis, Dactylitis, Temporomandibular Joint Arthritis, and Deprescribing Recommendations 11:58 Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Management, Medication Monitoring, and Imaging Recommendations 16:21 Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis Recommendations